A major milestone for digital pathology: TechCrunch has spotlighted Elea, the Hamburg-based health tech startup, for its groundbreaking approach to transforming pathology labs through artificial intelligence.

Founded in early 2024 by Dr. Christoph Schröder and Dr. Sebastian Casu, Elea has developed an AI-powered operating system that fully replaces outdated laboratory information systems. Leveraging speech-to-text transcription, intelligent task automation, and voice-controlled workflows, Elea drastically accelerates diagnostic reporting in pathology labs. In fact, initial data shows report turnaround times for many cases have been cut to just two days.

What sets Elea apart? Rather than offering yet another add-on for legacy EHRs, Elea integrates vertically—automating each lab task as a unified workflow. From slide preparation to structured report generation, Elea’s AI agent acts on clinicians’ spoken commands, eliminating manual typing and fragmented tools.

“Elea is not augmenting old systems—it replaces them,” says CEO Christoph Schröder in the TechCruncharticle.

The company is also making waves financially: Elea has successfully closed a €4 million seed funding round, led by Fly Ventures and Giant Ventures. These funds have fueled product development and implementation at Elea’s first partner lab—part of a major German hospital chain handling 70,000 cases annually.

As demand grows for scalable and efficient lab solutions, Elea’s vision extends far beyond Germany. With its cloud-based system accessible via iPad, Mac, or web, the startup is preparing for international expansion—particularly targeting the U.S. market.